MRP Capital Investments LLC lowered its stake in The Procter & Gamble Company (NYSE:PG - Free Report) by 70.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 2,955 shares of the company's stock after selling 6,886 shares during the quarter. MRP Capital Investments LLC's holdings in Procter & Gamble were worth $433,000 as of its most recent filing with the SEC.
Other institutional investors have also recently added to or reduced their stakes in the company. Wyrmwood Management LLC purchased a new position in Procter & Gamble in the 4th quarter valued at $29,000. Mendota Financial Group LLC lifted its holdings in Procter & Gamble by 636.6% in the 4th quarter. Mendota Financial Group LLC now owns 302 shares of the company's stock valued at $44,000 after purchasing an additional 261 shares in the last quarter. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble in the 2nd quarter valued at $50,000. CGC Financial Services LLC purchased a new position in Procter & Gamble in the 2nd quarter valued at $55,000. Finally, Morton Brown Family Wealth LLC lifted its holdings in Procter & Gamble by 206.6% in the 4th quarter. Morton Brown Family Wealth LLC now owns 417 shares of the company's stock valued at $61,000 after purchasing an additional 281 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Trading Down 0.3 %
NYSE PG traded down $0.51 during trading on Friday, hitting $155.33. The stock had a trading volume of 6,770,659 shares, compared to its average volume of 6,339,995. The company has a market capitalization of $365.49 billion, a PE ratio of 26.02, a PEG ratio of 3.19 and a beta of 0.44. The company has a quick ratio of 0.44, a current ratio of 0.64 and a debt-to-equity ratio of 0.48. The firm has a 50 day moving average price of $159.32 and a 200 day moving average price of $152.59. The Procter & Gamble Company has a twelve month low of $141.45 and a twelve month high of $163.14.
Procter & Gamble (NYSE:PG - Get Free Report) last released its earnings results on Tuesday, January 23rd. The company reported $1.84 earnings per share for the quarter, beating the consensus estimate of $1.70 by $0.14. The company had revenue of $21.44 billion during the quarter, compared to the consensus estimate of $21.48 billion. Procter & Gamble had a return on equity of 34.04% and a net margin of 17.60%. Procter & Gamble's revenue was up 3.2% compared to the same quarter last year. During the same period in the previous year, the company posted $1.59 EPS. As a group, equities research analysts forecast that The Procter & Gamble Company will post 6.45 earnings per share for the current year.
Procter & Gamble Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be given a dividend of $1.0065 per share. The ex-dividend date of this dividend is Thursday, April 18th. This is an increase from Procter & Gamble's previous quarterly dividend of $0.94. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.59%. Procter & Gamble's payout ratio is currently 62.98%.
Wall Street Analysts Forecast Growth
A number of brokerages have weighed in on PG. Raymond James raised their price objective on Procter & Gamble from $170.00 to $175.00 and gave the company an "outperform" rating in a report on Wednesday, January 24th. StockNews.com lowered Procter & Gamble from a "buy" rating to a "hold" rating in a report on Thursday, February 29th. The Goldman Sachs Group started coverage on Procter & Gamble in a report on Friday, March 1st. They set a "neutral" rating and a $168.00 price target on the stock. Deutsche Bank Aktiengesellschaft lifted their price target on Procter & Gamble from $170.00 to $172.00 and gave the stock a "buy" rating in a report on Wednesday, April 3rd. Finally, Wells Fargo & Company lifted their price target on Procter & Gamble from $162.00 to $170.00 and gave the stock an "overweight" rating in a report on Wednesday, January 24th. Seven investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $168.53.
Check Out Our Latest Stock Report on Procter & Gamble
Insider Transactions at Procter & Gamble
In other news, CEO Ma. Fatima Francisco sold 74,443 shares of the business's stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $153.30, for a total transaction of $11,412,111.90. Following the completion of the transaction, the chief executive officer now directly owns 973 shares of the company's stock, valued at $149,160.90. The sale was disclosed in a filing with the SEC, which is accessible through this link. In related news, CEO R. Alexandra Keith sold 776 shares of the company's stock in a transaction that occurred on Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the completion of the transaction, the chief executive officer now directly owns 4,859 shares of the company's stock, valued at $768,256.49. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Ma. Fatima Francisco sold 74,443 shares of the company's stock in a transaction that occurred on Wednesday, January 24th. The shares were sold at an average price of $153.30, for a total value of $11,412,111.90. Following the completion of the transaction, the chief executive officer now directly owns 973 shares of the company's stock, valued at $149,160.90. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 279,063 shares of company stock valued at $43,187,745. 0.17% of the stock is currently owned by corporate insiders.
About Procter & Gamble
(
Free Report)
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Featured Articles
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
